Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

H. Holte; Sirpa Leppä; M. Bjorkholm; O. Fluge; S. Jyrkkio; J. Delabie; C. Sundstrom; M. -L. Karjalainen-Lindsberg; M. Erlanson; A. Kolstad; A. Fossa; B. Ostenstad; E. Lofvenberg; M. Nordstrom; R. Janes; L. M. Pedersen; H. Anderson; M. Jerkeman; M. Eriksson

doi:10.1093/annonc/mds621

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

H. Holte, Sirpa Leppä, M. Bjorkholm, O. Fluge, S. Jyrkkio, J. Delabie, C. Sundstrom, M. -L. Karjalainen-Lindsberg, M. Erlanson, A. Kolstad, A. Fossa, B. Ostenstad, E. Lofvenberg, M. Nordstrom, R. Janes, L. M. Pedersen, H. Anderson, M. Jerkeman, M. Eriksson

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Annals of Oncology
Vuosikerta	24
Numero	5
Sivut	1385-1392
Sivumäärä	8
ISSN	0923-7534
DOI - pysyväislinkit	https://doi.org/10.1093/annonc/mds621
Tila	Julkaistu - toukok. 2013
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3122 Syöpätaudit

Pääsy asiakirjaan

10.1093/annonc/mds621

Siteeraa tätä

Holte, H., Leppä, S., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M. .-L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstrom, M., Janes, R., Pedersen, L. M., Anderson, H., Jerkeman, M., & Eriksson, M. (2013). Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. Annals of Oncology, 24(5), 1385-1392. https://doi.org/10.1093/annonc/mds621

@article{fccac592c8b348db92bdc4bc4cdd3047,

title = "Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study",

keywords = "age-adjusted IPI, central nervous system, diffuse large B-cell lymphoma, intensive chemotherapy, prophylaxis, NON-HODGKINS-LYMPHOMA, CHEMOTHERAPY PLUS RITUXIMAB, RANDOMIZED CONTROLLED-TRIAL, 3-WEEKLY CHOP CHEMOTHERAPY, CELL LYMPHOMA, ELDERLY-PATIENTS, AGGRESSIVE LYMPHOMAS, RESPONSE CRITERIA, PROGNOSTIC IMPACT, CNS PROPHYLAXIS, 3122 Cancers",

author = "H. Holte and Sirpa Lepp{\"a} and M. Bjorkholm and O. Fluge and S. Jyrkkio and J. Delabie and C. Sundstrom and Karjalainen-Lindsberg, \{M. -L.\} and M. Erlanson and A. Kolstad and A. Fossa and B. Ostenstad and E. Lofvenberg and M. Nordstrom and R. Janes and Pedersen, \{L. M.\} and H. Anderson and M. Jerkeman and M. Eriksson",

year = "2013",

month = may,

doi = "10.1093/annonc/mds621",

language = "English",

volume = "24",

pages = "1385--1392",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd. ",

number = "5",

}

Holte, H, Leppä, S, Bjorkholm, M, Fluge, O, Jyrkkio, S, Delabie, J, Sundstrom, C, Karjalainen-Lindsberg, M-L, Erlanson, M, Kolstad, A, Fossa, A, Ostenstad, B, Lofvenberg, E, Nordstrom, M, Janes, R, Pedersen, LM, Anderson, H, Jerkeman, M & Eriksson, M 2013, 'Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study', Annals of Oncology, Vuosikerta 24, Nro 5, Sivut 1385-1392. https://doi.org/10.1093/annonc/mds621

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. / Holte, H.; Leppä, Sirpa; Bjorkholm, M. et al.
julkaisussa: Annals of Oncology, Vuosikerta 24, Nro 5, 05.2013, s. 1385-1392.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

AU - Holte, H.

AU - Leppä, Sirpa

AU - Bjorkholm, M.

AU - Fluge, O.

AU - Jyrkkio, S.

AU - Delabie, J.

AU - Sundstrom, C.

AU - Karjalainen-Lindsberg, M. -L.

AU - Erlanson, M.

AU - Kolstad, A.

AU - Fossa, A.

AU - Ostenstad, B.

AU - Lofvenberg, E.

AU - Nordstrom, M.

AU - Janes, R.

AU - Pedersen, L. M.

AU - Anderson, H.

AU - Jerkeman, M.

AU - Eriksson, M.

PY - 2013/5

Y1 - 2013/5

KW - age-adjusted IPI

KW - central nervous system

KW - diffuse large B-cell lymphoma

KW - intensive chemotherapy

KW - prophylaxis

KW - NON-HODGKINS-LYMPHOMA

KW - CHEMOTHERAPY PLUS RITUXIMAB

KW - RANDOMIZED CONTROLLED-TRIAL

KW - 3-WEEKLY CHOP CHEMOTHERAPY

KW - CELL LYMPHOMA

KW - ELDERLY-PATIENTS

KW - AGGRESSIVE LYMPHOMAS

KW - RESPONSE CRITERIA

KW - PROGNOSTIC IMPACT

KW - CNS PROPHYLAXIS

KW - 3122 Cancers

U2 - 10.1093/annonc/mds621

DO - 10.1093/annonc/mds621

M3 - Article

SN - 0923-7534

VL - 24

SP - 1385

EP - 1392

JO - Annals of Oncology

JF - Annals of Oncology

IS - 5

ER -